PURSUIT risk score: Difference between revisions
Jump to navigation
Jump to search
Line 15: | Line 15: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+PURSUIT Risk Score | |+PURSUIT Risk Score | ||
!Elements | !Elements | ||
!Entry | !Entry | ||
Line 59: | Line 59: | ||
|} | |} | ||
*<br /> | === Interpretation === | ||
*The PURSUIT score predicts the risk of death or death/MI at 30 days after admission. | |||
*ACS patients are divided into low, intermediate, and high risk patients, with suggested therapies of early discharge, watchful waiting, and aggressive antiplatelet / early invasive strategies, respectively.<br /> | |||
<references /> |
Revision as of 22:45, 11 February 2020
Definition and History
The PURSUIT (Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy) risk score was developed in a randomized clinical trial which recruited 9,461 patients and compared eptifibatide (Integrilin) to placebo in the management of Unstable Angina (UA) or Non-ST elevation Myocardial Infarction (NSTEMI).
Function
- By using multivariate regression analysis, the investigators established seven risk predictors for death and myocardial infarction (MI) in patients with acute coronary syndromes.
- Five of these risk factors were then combined into a scoring system:
- Higher age
- Sex
- Worst Canadian Cardiovascular Society (CCS) class of angina
- Signs of heart failure
- ST-segment depression on the index ECG
- Each of these elements is scored accordingly, resulting in a score ranging 1 - 18.
Elements | Entry | Score |
---|---|---|
Age |
|
|
Sex |
|
|
Worst CCS class past 6 weeks |
|
|
Signs of heart failure |
| |
ST depression on ECG |
|
Interpretation
- The PURSUIT score predicts the risk of death or death/MI at 30 days after admission.
- ACS patients are divided into low, intermediate, and high risk patients, with suggested therapies of early discharge, watchful waiting, and aggressive antiplatelet / early invasive strategies, respectively.